58 related articles for article (PubMed ID: 14656979)
1. Pyridoxal 5'-phosphate as a novel weapon against autoimmunity and transplant rejection.
Namazi MR
FASEB J; 2003 Dec; 17(15):2184-6. PubMed ID: 14656979
[TBL] [Abstract][Full Text] [Related]
2. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71).
Chirmule N; McCloskey TW; Hu R; Kalyanaraman VS; Pahwa S
J Immunol; 1995 Jul; 155(2):917-24. PubMed ID: 7541827
[TBL] [Abstract][Full Text] [Related]
3. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120.
Dianzani U; Bragardo M; Buonfiglio D; Redoglia V; Funaro A; Portoles P; Rojo J; Malavasi F; Pileri A
Eur J Immunol; 1995 May; 25(5):1306-11. PubMed ID: 7539755
[TBL] [Abstract][Full Text] [Related]
4. A fungal metabolite which inhibits the interaction of CD4 with major histocompatibility complex-encoded class II molecules.
Gammon G; Chandler G; Depledge P; Elcock C; Wrigley S; Moore J; Cammarota G; Sinigaglia F; Moore M
Eur J Immunol; 1994 Apr; 24(4):991-8. PubMed ID: 8149967
[TBL] [Abstract][Full Text] [Related]
5. Potent inhibition of the CD4-dependent T cell response by J2, a novel nonpeptide organic ligand of CD4 D1.
Xiao H; Feng JN; He XH; Zhang H; Zhang JR; Zhang L; Yu M; Huang YF; Li S; Shen BF; Li Y
Mol Immunol; 2007 Feb; 44(5):784-95. PubMed ID: 16787663
[TBL] [Abstract][Full Text] [Related]
6. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
Lustgarten J; Waks T; Eshhar Z
Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
[TBL] [Abstract][Full Text] [Related]
7. Modulation of CD4 co-receptor limits spontaneous autoimmunity when high-affinity transgenic TCR specific for self-antigen is expressed on a genetically resistant background.
Illés Z; Waldner H; Reddy J; Anderson AC; Sobel RA; Kuchroo VK
Int Immunol; 2007 Oct; 19(10):1235-48. PubMed ID: 17804690
[TBL] [Abstract][Full Text] [Related]
8. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells.
Rathmell JC; Cooke MP; Ho WY; Grein J; Townsend SE; Davis MM; Goodnow CC
Nature; 1995 Jul; 376(6536):181-4. PubMed ID: 7603571
[TBL] [Abstract][Full Text] [Related]
9. Specific inhibition of CD4+ T lymphocytes by a hybrid antibody.
Qi Y; Staerz UD
Nat Biotechnol; 1998 Mar; 16(3):271-5. PubMed ID: 9528008
[TBL] [Abstract][Full Text] [Related]
10. Isotypic residues in the membrane proximal domain of MHC class II beta-chains control activation of CD4+ T cells.
Sant AJ
J Immunol; 1993 Jun; 150(12):5299-310. PubMed ID: 8099935
[TBL] [Abstract][Full Text] [Related]
11. Purified beta-chain of MHC class II binds to CD4 molecules on transfected HeLa cells.
Nag B; Wada HG; Passmore D; Clark BR; Sharma SD; McConnell HM
J Immunol; 1993 Feb; 150(4):1358-64. PubMed ID: 8432982
[TBL] [Abstract][Full Text] [Related]
12. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
Herkel J; Jagemann B; Wiegard C; Lazaro JF; Lueth S; Kanzler S; Blessing M; Schmitt E; Lohse AW
Hepatology; 2003 May; 37(5):1079-85. PubMed ID: 12717388
[TBL] [Abstract][Full Text] [Related]
13. Profound enhancement of T cell activation mediated by the interaction between the TCR and the D3 domain of CD4.
Vignali DA; Vignali KM
J Immunol; 1999 Feb; 162(3):1431-9. PubMed ID: 9973399
[TBL] [Abstract][Full Text] [Related]
14. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
[TBL] [Abstract][Full Text] [Related]
15. Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1.
Matthias LJ; Yam PT; Jiang XM; Vandegraaff N; Li P; Poumbourios P; Donoghue N; Hogg PJ
Nat Immunol; 2002 Aug; 3(8):727-32. PubMed ID: 12089508
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic applications of anti-CD4 antibodies.
Olive D; Mawas C
Crit Rev Ther Drug Carrier Syst; 1993; 10(1):29-63. PubMed ID: 8472311
[TBL] [Abstract][Full Text] [Related]
17. Some cloned murine CD4+ T cells recognize H-2Ld class I MHC determinants directly. Other cloned CD4+ T cells recognize H-2Ld class I MHC determinants in the context of class II MHC molecules.
McKisic MD; Sant AJ; Fitch FW
J Immunol; 1991 Nov; 147(9):2868-74. PubMed ID: 1717578
[TBL] [Abstract][Full Text] [Related]
18. T-cell vaccination against anti-CD4 autoimmunity in HIV-1 infected patients.
Abulafia-Lapid R; Bentwich Z; Keren-Zur Y; Cohen IR; Atlan H
J Clin Virol; 2004 Dec; 31 Suppl 1():S48-54. PubMed ID: 15567094
[TBL] [Abstract][Full Text] [Related]
19. Differential susceptibility to monomeric HIV gp120-mediated apoptosis in antigen-activated CD4+ T cell populations.
Tuosto L; Gilardini Montani MS; Lorenzetti S; Cundari E; Moretti S; Lombardi G; Piccolella E
Eur J Immunol; 1995 Oct; 25(10):2907-16. PubMed ID: 7589091
[TBL] [Abstract][Full Text] [Related]
20. Envelope glycoproteins of HIV-1 interfere with T-cell-dependent B cell differentiation: role of CD4-MHC class II interaction in the effector phase of T cell help.
Chirmule N; Wang XP; Hu R; Oyaizu N; Roifman C; Pahwa R; Kalyanaraman VS; Pahwa S
Cell Immunol; 1994 Apr; 155(1):169-82. PubMed ID: 8168144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
